DCC-2036

DCC-2036 (Rebastinib) is a highly potent, non-ATP-competitive BCR-ABL1 inhibitor with IC50 of 0.8 and 4 nM for native ABL1 and gatekeeper mutant ABL1 T315I, respectively.

Product Specifications

CAS Number

1020172-07-9

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

553.5869

Molecular Formula

C30H28FN7O3

Notes

Research use only, not for human use.

Receptor

Abl1|FLT3|p-Abl1 (native) |p-Abl1 (T315I) |u-Abl1 (native)

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

P503048 100 µg

CYP24A1 Protein (N-His, Human)

Ask

View Details

E53P04791 100 µL

LYAR Rabbit Polyclonal Antibody

Ask

View Details

OM637268-01 100 µL

Phospho-GATA3 (S308) [ST44-09] Antibody

Ask

View Details

OM637268-02 20 µL

Phospho-GATA3 (S308) [ST44-09] Antibody

Ask

View Details

OM637268-03 50 µL

Phospho-GATA3 (S308) [ST44-09] Antibody

Ask

View Details

MBS741689-01 48 Well

Mouse b Endorphin ELISA Kit

Ask

View Details